188 related articles for article (PubMed ID: 34145769)
1. In Vivo Tracking of the Degradation of Mesoporous Silica through
Bindini E; Ramirez MLA; Rios X; Cossío U; Simó C; Gomez-Vallejo V; Soler-Illia G; Llop J; Moya SE
Small; 2021 Jul; 17(30):e2101519. PubMed ID: 34145769
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles.
Chen F; Goel S; Valdovinos HF; Luo H; Hernandez R; Barnhart TE; Cai W
ACS Nano; 2015 Aug; 9(8):7950-9. PubMed ID: 26213260
[TBL] [Abstract][Full Text] [Related]
4. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
[TBL] [Abstract][Full Text] [Related]
5. Following in Situ the Degradation of Mesoporous Silica in Biorelevant Conditions: At Last, a Good Comprehension of the Structure Influence.
Bindini E; Chehadi Z; Faustini M; Albouy PA; Grosso D; Cattoni A; Chanéac C; Azzaroni O; Sanchez C; Boissière C
ACS Appl Mater Interfaces; 2020 Mar; 12(12):13598-13612. PubMed ID: 32077678
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.
Ellison PA; Chen F; Goel S; Barnhart TE; Nickles RJ; DeJesus OT; Cai W
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6772-6781. PubMed ID: 28165700
[TBL] [Abstract][Full Text] [Related]
8. Core
Ramírez MLÁ; Martínez-Villacorta ÁM; Gómez-Vallejo V; Andreozzi P; Soler-Illia G; Llop J; Moya SE
Nanoscale Adv; 2022 May; 4(9):2098-2106. PubMed ID: 36133445
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape.
Li L; Liu T; Fu C; Tan L; Meng X; Liu H
Nanomedicine; 2015 Nov; 11(8):1915-24. PubMed ID: 26238077
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and Excretion of Intravenously Injected Mesoporous Silica Nanoparticles: Implications for Drug Delivery Efficiency and Safety.
Lindén M
Enzymes; 2018; 43():155-180. PubMed ID: 30244806
[TBL] [Abstract][Full Text] [Related]
11. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
12. Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors.
Chen G; Teng Z; Su X; Liu Y; Lu G
J Biomed Nanotechnol; 2015 Apr; 11(4):722-9. PubMed ID: 26310078
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous multi-silica layer-coated Y
Ansari AA; Khan A; Labis JP; Alam M; Aslam Manthrammel M; Ahamed M; Akhtar MJ; Aldalbahi A; Ghaithan H
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():365-373. PubMed ID: 30606544
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties.
El-Toni AM; Khan A; Ibrahim MA; Labis JP; badr G; Al-Hoshan M; Yin S; Sato T
J Colloid Interface Sci; 2012 Jul; 378(1):83-92. PubMed ID: 22551476
[TBL] [Abstract][Full Text] [Related]
15. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
17. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
18. Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery.
Li Y; Li N; Pan W; Yu Z; Yang L; Tang B
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2123-2129. PubMed ID: 28004570
[TBL] [Abstract][Full Text] [Related]
19. ROS-Responsive Janus Au/Mesoporous Silica Core/Shell Nanoparticles for Drug Delivery and Long-Term CT Imaging Tracking of MSCs in Pulmonary Fibrosis Treatment.
Li X; Li Y; Yu C; Bao H; Cheng S; Huang J; Zhang Z
ACS Nano; 2023 Apr; 17(7):6387-6399. PubMed ID: 36946383
[TBL] [Abstract][Full Text] [Related]
20. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
Ran Z; Sun Y; Chang B; Ren Q; Yang W
J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
